HSIC241220P100000
- 0.00
- 0.000.00%
Henry Schein Newsroom
Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs
S&P 500, Dow Hit Records Right After Open | Live Stock
Are Wall Street Analysts Bullish on Henry Schein Stock?
Activist Ananym Has a List of Suggestions for Henry Schein. How the Firm Can Help Improve Profits
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Henry Schein to Participate in Investor Conferences in December
Hold Rating Maintained for Henry Schein Amid Market Challenges and Activist Investor Influence
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Market Falls on Retail Results, Bitcoin Swells, All Eyes on Nvidia | Live Stock
Peering Into Henry Schein's Recent Short Interest
Henry Schein to Acquire Medical Products Supplier Acentus
Henry Schein: Acentus Has Annual Revenue of About $35 Million >HSIC